medical_technology

Melbourne – September 04, 2026 -- SIBIONICS showcased its GS3 continuous glucose monitoring (CGM) sensor, integrating artificial intelligence for meal logging, food analysis and glucose trend insights, at the joint IDF-WPR, ADC and Metabolic Diseases 2026 congress held in Melbourne from August 18 to 21.

SIBIONICS repurposes brain-computer interface technology for a 14-day glucose sensor

The GS3 traces its technological origin to SIBIONICS' work on brain-computer interfaces, including a retinal prosthesis designed for patients with severe vision loss from degenerative retinal diseases such as retinitis pigmentosa. The company adapted this high-precision biosensing and signal-processing engineering into the GS3, a factory-calibrated CGM sensor with a 14-day lifespan and a 2.9mm thickness aimed at reducing user discomfort.

Frankfurt (Oder), Germany -- Klinikum Frankfurt (Oder) opened a new hybrid operating room on Aug. 31, 2026, backed by roughly 6 million euros in investment, RHÖN-KLINIKUM AG announced. The facility, one of five hospitals in the Rhön-Klinikum network, will serve as the primary site for vascular surgery and cardiology teams treating complex vascular and cardiac cases across eastern Brandenburg. Hospital managing director Christian Petersen and chief medical officer Prof. Richter-Ehrenstein presented the room as a step toward offering high-end interventional procedures rarely available outside specialized centers.